"Valve in valve" percutaneous aortic valve implantation for severe mixed bioprosthetic aortic valve disease.

Abstract

Transcatheter aortic valve implantation (TAVI) is an effective treatment for patients with severe aortic stenosis at high risk for surgical valve replacement. We present a case of successful, off-label transfemoral valve-in-valve implantation of the self-expandable Medtronic-CoreValve prosthesis in an inoperable elderly patient with structural deterioration of an existing bioprosthesis in the aortic position. This case illustrates that TAVI for a deteriorated aortic bioprosthesis is feasible in a patient who was not suitable for reoperation.

• Authors: Frederic De Vroey, Malcolm Legget, John Ormiston, Mark Webster, James Stewart
• Journal: The New Zealand medical journal (N Z Med J) Vol. 125 Issue 1353 Pg. 146-8 (Apr 20 2012) ISSN: 1175-8716 [Electronic] New Zealand
• PMID: 22522275 (Publication Type: Case Reports, Journal Article)

Topics

• Aged
• Bioprosthesis
• Catheterization
• Female
• Heart Valve Prosthesis
• Heart Valve Prosthesis Implantation (methods)
• Humans
• Mitral Valve (surgery)